ArticleScientific reports2025
A multimodal MRI-based machine learning framework for classifying cognitive impairment in cerebral small vessel disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Risk prediction models for cognitive impairment in patients with cerebral small vessel disease: a systematic review and meta-analysis.Frontiers in aging neuroscience · 2026Pooled it
- Optimizing MRI sequence selection for glioma classification: a radiomics-based analysis of WHO CNS grade, final pathological diagnosis, and IDH status.La Radiologia medica · 2026Article
- Early identification of vascular cognitive impairment from a multimodal perspective: a combined diagnosis from targeted cognitive assessments, imaging biomarkers, and molecular fluid biomarkers to ecological behavioral characteristics.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Review
- Exploratory Associations Between Multimodal MRI-Derived Features and Neurological Symptoms in Wolfram Syndrome: A Spanish Cohort Pilot Study.Diagnostics (Basel, Switzerland) · 2026Article
- [Progress on prognostic assessment methods for mild cognitive impairment].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026Review
- Deep Learning for Classifying and Cognitive Profiling of Subcortical Vascular Cognitive Impairment.Cyborg and bionic systems (Washington, D.C.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The heterogeneity of cerebral small vessel disease (CSVD) with mild cognitive impairment (MCI) presents a challenge for diagnosis and classification. This study aims to propose a multimodal magnetic resonance imaging (MRI)-based machine learning framework to effectively classify MCI and NCI in CSVD patients. We enrolled 165 CSVD patients, categorized into NCI (n = 81) and MCI (n = 84) groups based on neurocognitive assessments. Multimodal MRI data, including T1-weighted, resting-state functional MRI, and diffusion tensor images, were collected. Image preprocessing, feature extraction and selection were applied to obtain MRI features from three modalities. The AutoGluon platform was utilized for model development, and traditional machine learning algorithms were applied for comparison. The models were validated using a validation cohort of 83 CSVD patients, and their performance was assessed via receiver operating characteristic curve analysis. The AutoGluon model to distinguish MCI from NCI based on multimodal MRI features demonstrated high area under the curve (AUC), accuracy, sensitivity, specificity, precision, balanced accuracy, and F1-score in the training cohort (0.926, 88.48%, 88.10%, 88.89%, 89.16%, 88.50%, and 88.63%, respectively) and validation cohort (0.878, 81.93%, 86.36%, 76.92%, 80.85%, 81.64%, and 83.51%, respectively). Other traditional machine learning models had AUCs of 0.755-0.831, and their prediction accuracies were significantly lower than that of AutoGluon model (P < 0.001). Our study provides a multimodal MRI-based machine learning framework, utilizing the AutoGluon platform, that outperforms traditional algorithms in classifying MCI and NCI, offering a promising tool for the early prediction of MCI in CSVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.